Germany bladder cancer market is estimated to grow considerably, at a CAGR of around 9.9% during the forecast period. Germany has a considerable market share in the global bladder cancer market due to the increasing geriatric population, presence of highly specialized urologists for cancer treatment and a bit lower cost treatment as compared to the UK, attracting medical tourism in the country.